There are 2 versions of Microgynon: Microgynon 30 has a pack of just 21 pills, and you do not take pills for the week of your period. deep venous thrombosis [DVT] or pulmonary embolism [PE]), o Known hereditary or acquired predisposition for venous thromboembolism, such as APC-resistance, (including Factor V Leiden), antithrombin-III-deficiency, protein C deficiency, protein S deficiency, o Major surgery with prolonged immobilisation (see section 4.4), o A high risk of venous thromboembolism due to the presence of multiple risk factors (see section 4.4), • Presence or risk of arterial thromboembolism (ATE), o Arterial thromboembolism – current arterial thromboembolism, history of arterial thromboembolism (e.g. And what where your symptoms? cyclosporin, tizanidine, theophylline) or decrease (e.g. Microgynon 30 is a combined oral contraceptive pill (‘the Pill’). Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, fructose intolerance or glucose-galactose malabsorption or sucrase-isomaltase should not take this medicine. Ingestion of Microgynon 30 leads to maximum plasma levels of approx. Does this meI'm'am pregnant? In women with fully established lactation, around 0.02% of the maternal dose can be passed on to the baby with the breast milk. Is pregnancy possible while on Microgynon 30? The recommended way of using Microgynon 30 pills is to start taking them from the first day of your menstrual cycle for the next 21 days without any gap. A steady state is reached during the second half of the treatment cycle. Interactions can occur with drugs that induce microsomal enzymes (especially cytochrome P450 3A4) which can result in increased clearance of sex hormones and which may lead to breakthrough bleeding and/or contraceptive failure. I came off Microgynon after about 8 years, waited for my first period which came the next month and fell pregnant the next month. Benefits of Microgynon 30 ED The decision to prescribe Microgynon 30 should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Microgynon 30 compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4). For further information, see sections 4.3 'Contraindications' and 4.4 'Special warnings and precautions for use'. The increased risk of VTE during the postpartum period should be considered when re-starting Microgynon 30 (see section 4.2 and 4.4). Diabetics with existing vascular disease are contraindicated from using COCs (see section 4.3 Contraindications). abdominal, orthopaedic), any surgery to the legs, medical treatment for varicose veins or prolonged immobilisation, e.g. We had unprotected intercourse on December 15, 2012 which was also the day of her last pill. Pregnancy rates in the United States between 1990 and 2009, by age (per 1,000 women) [Graph]. Find out more about how we use your information in our Privacy Policy and Cookie Policy. I loved this pill but docs have changed me now to the mini pill Micronor which i hate with a vengeance as i bleed irratically now, feel bloated and hate not … Microgynon is a pill you can take to prevent pregnancy. Microgynon 30 suited me perfectly! The following adverse events have been reported during use of ethinylestradiol / levonorgestrel: Adverse events reported in clinical trials, Venous thromboembolism (VTE), Arterial thromboembolism (ATE), reduced menstrual flow, spotting, breakthrough bleeding and missed withdrawal bleeding, post pill amenorrhoea, Description of selected adverse reactions. Only around 1.5% of the respective total concentration is present in unbound form, while approx. In rare cases benign and, in even rarer cases, malignant liver tumours leading in isolated cases to life-threatening intra-abdominal haemorrhage have been observed after the use of hormonal substances such as those contained in Microgynon 30. corticosteroid binding globulin and lipid/lipoprotein fractions, parameters of carbohydrate metabolism and parameters of coagulation and fibrinolysis. This information is intended for use by health professionals, For full list of excipients, see section 6.1.